Cargando…
Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
Diverse neurological symptoms have been reported in patients with SARS-CoV-2 disease (COVID-19), including stroke, ataxia, meningitis, encephalitis, and cognitive impairment. These alterations can cause serious sequelae or death and are associated with the entry of SARS-CoV-2 into the Central Nervou...
Autores principales: | Hernández-Parra, Héctor, Reyes-Hernández, Octavio Daniel, Figueroa-González, Gabriela, González-Del Carmen, Manuel, González-Torres, Maykel, Peña-Corona, Sheila I., Florán, Benjamín, Cortés, Hernán, Leyva-Gómez, Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043238/ https://www.ncbi.nlm.nih.gov/pubmed/36998270 http://dx.doi.org/10.3389/fncel.2023.1125109 |
Ejemplares similares
-
A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
por: Cortés, Hernán, et al.
Publicado: (2020) -
Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021) -
Formulations of Curcumin Nanoparticles for Brain Diseases
por: Del Prado-Audelo, María L., et al.
Publicado: (2019) -
Insights into Terminal Sterilization Processes of Nanoparticles for Biomedical Applications
por: Bernal-Chávez, Sergio A., et al.
Publicado: (2021) -
Modifications in Vaginal Microbiota and Their Influence on Drug Release: Challenges and Opportunities
por: Leyva-Gómez, Gerardo, et al.
Publicado: (2019)